gabapentin 100 mg

INDICATIONS AND USAGE Postherpetic Neuralgia Gabapentin capsules, USP are indicated for the Management of postherpetic neuralgia in adults. Epilepsy Gabapentin capsules, USP are indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in patients over 12 years of age with epilepsy. Gabapentin capsules, USP are also indicated as adjunctive therapy in the treatment of partial seizures in pediatric patients age 3 to 12 years.

Aphena Pharma Solutions - Tennessee, LLC

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] nausea` `[3] fatigue` `[4] diarrhoea` `[5] dyspnoea` `[6] off label use` `[7] pain` `[8] headache` `[9] vomiting` `[10] death`

1 year ago

CAPSULE WHITE D 02

1 year ago

D 02 CAPSULE WHITE

HOW SUPPLIED Repackaged by Aphena Pharma Solutions - TN. See Repackaging Information for available configurations.

GABAPENTIN capsules USP, 100 mg are white/white size ‘3’ hard gelatin capsules imprinted with ‘D’ on white cap and ‘02’ on white body with black edible ink filled with white to off-white crystalline powder. Bottles of 90 NDC 52343-030-90 Bottles of 100 NDC 52343-030-01 Bottles of 180 NDC 52343-030-18 Bottles of 270 NDC 52343-030-27 Bottles of 500 NDC 52343-030-05 Bottles of 1000 NDC 52343-030-99

GABAPENTIN capsules USP, 300 mg are yellow/yellow size ‘1’ hard gelatin capsules imprinted with ‘D’ on yellow cap and ‘03’ on yellow body with black edible ink filled with white to off-white crystalline powder. Bottles of 30 NDC 52343-031-30 Bottles of 60 NDC 52343-031-60 Bottles of 90 NDC 52343-031-90 Bottles of 100 NDC 52343-031-01 Bottles of 180 NDC 52343-031-18 Bottles of 270 NDC 52343-031-27 Bottles of 500 NDC 52343-031-05 Bottles of 1000 NDC 52343-031-99

GABAPENTIN capsules USP, 400 mg are orange/orange size ‘0’ hard gelatin capsules imprinted with ‘D’ on orange cap and ‘04’ on orange body with black edible ink filled with white to off-white crystalline powder. Bottles of 90 NDC 52343-032-90 Bottles of 100 NDC 52343-032-01 Bottles of 270 NDC 52343-032-27 Bottles of 500 NDC 52343-032-05 Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Maalox ® is a registered trademark of Novartis Consumer Health, Inc. Manufactured by: Aurolife Pharma LLC Dayton, NJ 08810 Manufactured for: Cedardale Distributors D/B/A Gen-Source RX 620 Gotham Parkway Carlstadt, NJ 07072 USA Issued: 03/2013

More pills like CAPSULE D 02

Related Pills

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site